ChiCTR2200062210
Untitled Trial
Risk Factors for Postoperative Intensive Care Unit Admission after Colorectal Cancer Surgery.
General Hospital of Ningxia Medical University·Phase 1·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- colorectal cancer
Sponsor & location
- Primary sponsor
- General Hospital of Ningxia Medical University
- Funder
- National Natural Science Foundation of China
- Location
- China
Timeline & enrollment
- Phase
- Phase 1
- Start date
- N/A
- End date
- May 15, 2023
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200062210
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200062210 through Pure Global AI's free database. This Phase 1 trial is sponsored by General Hospital of Ningxia Medical University and is currently Recruiting. The study focuses on colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.